The insider activity is minor in scale and typical for executives managing option portfolios; no signal of distress or confidence. Monitor upcoming earnings or pipeline updates for material catalysts.
CGEN drugs
CGEN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 26 $2.06entry
- T+1 · 8mo ago −0.97%α +0.71% · $2.04
- T+5 · 8mo ago +9.71%α +8.08% · $2.26
- T+20 · 7mo ago +50.49%α +39.82% · $3.10
- T+60 · 5mo ago +0.97%α −12.98% · $2.08
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Compugen CEO Ophir Eran sold $12.4K of stock and exercised two tranches of options, one at zero cost and another at $0.83 per share, while SVP Levine Zurit sold $24K of shares in a recent insider cluster totaling $37K. The sales represent less than 0.1% of the company's $214M market cap and are consistent with routine post-exercise selling.
Key Financial Metrics
Key Facts
- CEO Ophir Eran sold 5,625 shares for $12,413 on April 1, 2026, following the exercise of 11,250 options (5,625 at $0, 5,625 at $0.8292).
- SVP Levine Zurit sold 11,900 shares for $24,000 on March 26, 2026.
- Total insider selling in the past 7 days: $37,000 across two insiders.
- All transactions occurred at market prices with no block discounts or unusual timing.
Financial Impact
$37,000 in total open-market sales, representing 0.017% of $214M market cap
Risk Factors
- Minimal dilution from option exercises, but economically insignificant.
- Perception risk if media mischaracterizes zero-cost option exercise as 'selling at $0'.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CGEN-1775215810179 |
Track record
9 reports on CGEN
Filters
- Nov 9, 20267d ago 6-K Neutral 4/10 Entry $2.14 Now $2.04 −4.67% settles Dec 8
- Aug 3, 202615w ago 6-K Neutral 2/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Aug 3, 202615w ago 6-K Neutral 4/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Jun 9, 202623w ago EFFECT Neutral 3/10 Entry $2.02 to $2.39 Now $2.04 +0.99% ▲ +18.32% +16.87% vs SPY
- May 18, 202626w ago 6-K Neutral 4/10 Entry $2.86 to $2.03 Now $2.04 −28.67% ▼ −29.02% −30.60% vs SPY
- Apr 24, 202629w ago Insider Cluster Neutral 2/10 Entry $3.10 to $2.61 Now $2.04 −34.19% ▼ −15.81% −19.83% vs SPY
- Apr 14, 202631w ago Insider Cluster Neutral 2/10 Entry $2.88 to $2.87 Now $2.04 −29.17% ▼ −0.35% −6.64% vs SPY
- Apr 13, 202631w ago 144 Neutral 3/10 Entry $2.76 to $2.87 Now $2.04 −26.09% ▲ +3.99% −3.74% vs SPY
- Mar 26, 202633w ago Insider Cluster Neutral 3/10 Viewing Entry $2.06 to $3.10 Now $2.04 −0.97% ▲ +50.49% +39.82% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers